Specific chimeric antigen receptor T cell targeting nkg2dl, preparation method and application thereof
A chimeric antigen receptor and specific technology, applied in the field of tumor immunotherapy and biomedicine, can solve the problems of low killing efficiency and weak specificity, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0248] In the eighth aspect, the present application provides the method for preparing the isolated chimeric antigen receptor-modified immune response cells according to the sixth aspect of the present application, comprising the following steps:
[0249] Firstly, the nucleic acid molecule described in the third aspect is connected to an expression vector by means of molecular cloning to obtain an expression vector targeting NKG2DL-specific chimeric antigen receptor;
[0250] Then, transfect the obtained specific CAR expression vector targeting NKG2DL into 293T cells to obtain virus fluid;
[0251] Finally, the virus liquid is used to infect the immune response cells, and the modified immune response cells expressing the specific chimeric antigen receptor targeting NKG2DL are obtained from the infected cells.
[0252] In some non-limiting embodiments, the modified immune response cells of the present invention may be cells of the lymphoid lineage. The cells of the lymphoid li...
Embodiment 1
[0289] Preparation of expression plasmids targeting NKG2DL-specific chimeric antigen receptors
[0290] Step 1) Determination of the amino acid sequence of the specific chimeric antigen receptor targeting NKG2DL
[0291] First, the full-length amino acid sequence (as shown in SEQ ID No.1) and the full-length nucleotide sequence (as shown in SEQ ID No. .2).
[0292] Second, construct a specific chimeric antigen receptor targeting NKG2DL.
[0293] details as follows:
[0294] The amino acid sequence of the NKG2DL-specific CAR molecule: from the amino terminal to the carboxyl terminal, the amino acid sequence of the guide peptide (as shown in SEQ ID No.3), the human NKG2D amino acid sequence (as shown in SEQ ID No.4, , the amino acid sequence of the human CD8 hinge region (as shown in SEQ ID No.10), the amino acid sequence of the human CD8 transmembrane region (as shown in SEQ ID No.11), the amino acid sequence of the human 4-1BB intracellular domain ( shown in SEQ ID No.12),...
Embodiment 2
[0320] Example 2 Preparation of expression plasmids targeting NKG2DL-specific chimeric antigen receptors
[0321] In addition to step 1, the human NKG2D sequence (as shown in SEQ ID No.5) in the amino acid sequence of the CAR molecule targeting NKG2DL specificity, the amino acid sequence of the human CD3ζ domain is shown in SEQ ID No.15, targeting NKG2DL specificity The nucleotide sequence encoding the human NKG2D sequence (as shown in SEQ ID No.18) in the nucleotide sequence of the CAR molecule,
[0322] and step 2) construction and identification of a plasmid expressing a specific CAR molecule targeting NKG2DL
[0323] The nucleotide sequence of the specific CAR molecule targeting NKG2DL was synthesized from the whole gene, and connected to the lentiGuide-Puro lentiviral vector (Nanjing Yidao Bio, figure 1 ), constructing the full-length CAR sequence expression frame stage of a single coding frame, using the EFS promoter (SEQ ID No., 30 in the sequence table), and the rest ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com